Robots are revolutionizing the medical world. Vitruvia is the first technology company in Europe to harness the benefits of artificial intelligence (AI) for reprocessing complex instruments used in robot-assisted surgery, marketing its validated processes under the name Robot iQ.

Robot-assisted surgery is increasingly used for minimally invasive procedures such as complex cancer surgery. The da Vinci® surgical system by Intuitive Surgical® 
is currently the most commonly used surgical robot worldwide, but several other suppliers are now also becoming active in this lucrative market, among them Medtronic, Titan Medical, CMR Surgical, Verb Surgical, Avatera and TransEnterix.

The hygienic and economical reprocessing of these complex surgical instruments presents great challenges to healthcare institutions, with many currently still performing this regime in-house. The most pressing issue here, besides high investments and running costs, is lack of hygiene.

Robot iQ by Vitruvia sets completely new benchmarks for safe reprocessing of robotic instruments and complex medical devices. In addition to modern validated processes, the use of innovative technologies such as artificial intelligence (AI) ensures the highest standards of processes and hygiene.

An integrated quality management (IQ) system and comprehensive documentation enables hospitals to provide proof of the individual process steps at any time, in accordance with the legal requirements. The risk management, meanwhile, is handled entirely by Vitruvia.

About Vitruvia

Vitruvia is Europe‘s foremost technology company in the healthcare sector of the circular economy. As a supplier of innovative circular systems for highly complex medical devices, particularly in robot-assisted surgery, Vitruvia supports hospitals in the transformation of their ORs to higher value added, increased safety and maximum resource efficiency.

The company has offices in Berlin, Hamburg, Magdeburg, Schönbeck/Elbe and Anglikon/Switzerland.

For more information visit: www.vitruvia-med.com

Press contact:
Vitruvia AG
Beate Schemmer
Head of Marketing
T +49 (0)30 588 00 57 16
schemmer@vitruvia-med.com